# ASTERDM (ASTERDM) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/asterdm

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹755.05
- Change: -0.74%
- As of: 2026-09-18
- 1D return: -0.74%
- 5D return: -1.49%
- 1M return: -1.38%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, ASTERDM's technical stance is mixed across timeframes, with a bearish signal on the daily chart contrasting with bullish undertones on weekly and monthly views. The daily trend shows the price below key moving averages including the 20-day EMA (770.53) and 50-day EMA (780.66), with a bearish Supertrend at 797.85. This is supported by a declining ADX of 19.82, suggesting a lack of strong trend momentum. However, the weekly and monthly charts present a more constructive picture. The weekly trend is bullish with the Supertrend at 691.10 and the price above the 50-day EMA (711.01). Similarly, the monthly trend is bullish, indicated by the Supertrend at 535.05 and the price above the 20-day EMA (661.28). The stock is currently positioned near its nearest support at 754.37 (0.09% below the current price) and faces resistance around 770.68 (2.07% above the current price).

Recent market activity shows 7 events in the last 30 days, with 2 downside events, 1 positive attention event, and 2 neutral events. The stock's annualized volatility is 30%, with a current drawdown of -13% and a maximum drawdown of -26%. The nearest resistance is observed at 770.68, followed by 773.34. Key support levels are identified at 754.37 and 744.33. The active Doji pattern on the monthly chart on September 18, 2026, suggests potential indecision. The divergence between the daily bearish trend and the longer-term bullish trends warrants close observation.

- The stock closed at ₹755.05 on September 18, 2026.
- Nearest support is ₹754.37 (0.09% below current price).
- Nearest resistance is ₹770.68 (2.07% above current price).
- Daily trend is bearish, while weekly and monthly trends are bullish.
- Annualized volatility is 30% with a current drawdown of -13%.

- Doji
- Morning Star
- Inside Bar
- Bullish Engulfing Reversal

### What Changed

As of September 18, 2026, Aster DM Healthcare's stock price has seen a slight decrease, closing at ₹755.05 compared to its previous price of ₹762.1. The available evidence does not indicate any new filings or news developments for the company on this date. The daily and weekly trends are not specified in the provided data. Therefore, the primary recent change observed is the minor price fluctuation.

- On September 18, 2026, Aster DM Healthcare's stock closed at ₹755.05.
- This represents a decrease from the previous price of ₹762.1.
- No new filings or news were reported for Aster DM Healthcare on September 18, 2026.

### Official Filings

Aster DM Quality Care Limited has disclosed several significant developments. On September 2, 2026, the promoter group, through Union (Mauritius) Holdings Ltd., increased its stake by approximately 0.57% to 24.58% by acquiring 46.09 lakh equity shares for ₹350.34 crore. This transaction occurred on September 2, 2026, with shares purchased from TPG-backed Centella Mauritius Holdings Limited at ₹760 per share.

In a separate development, the company announced on September 8, 2026, a proposal to expand its Trivandrum facility by adding approximately 184 beds by May 2028. This expansion, named the KIMSHEALTH New Block, requires an investment of INR 1.344 billion, to be financed by 70% debt and 30% equity. This initiative aims to address space constraints and strengthen key specialties.

Furthermore, a material subsidiary, KIMS Healthcare Management Limited (KHML), received an upgraded credit rating from ICRA to [ICRA]AA (Stable) from [ICRA]AA- on September 16, 2026. This upgrade reflects KHML's improved credit profile, evidenced by its revenue growth of approximately 23% in FY2026 and an operating margin improvement to 30.2% from 26.2% in FY2025. As of March 31, 2026, KHML's total debt to OPBDITA stood at 0.4 times.

The company also provided its Business Responsibility and Sustainability Report for FY2025-26 on September 5, 2026, detailing outcomes such as sourcing 30% of electricity from renewable sources and avoiding over 16,000 tonnes of CO2e emissions. The 18th Annual General Meeting is scheduled for September 28, 2026, where resolutions include re-appointing a director and seeking approval to increase lending and investment limits to subsidiaries.

- On September 2, 2026, the promoter group acquired an additional 46.09 lakh equity shares for approximately ₹350.34 crore, increasing their stake to 24.58%.
- On September 8, 2026, the company proposed a capacity expansion of approximately 184 beds in Trivandrum by May 2028, requiring an investment of INR 1.344 billion (70% debt, 30% equity).
- On September 16, 2026, a material subsidiary, KHML, had its long-term credit rating upgraded to [ICRA]AA (Stable) from [ICRA]AA- by ICRA.
- KHML reported revenue growth of approximately 23% in FY2026 and an operating margin of 30.2% for FY2026, with total debt/OPBDITA at 0.4 times as of March 31, 2026.
- The 18th Annual General Meeting is scheduled for September 28, 2026, with proposed resolutions to increase lending and investment limits to subsidiaries.

- Aster DM Quality Care Limited has informed the Exchange about revision in Credit Rating of a Material Subsidiary |SUBJECT: Credit Rating- Revision
- ASTER DM QUALITY CARE LIMMITED has informed the Exchange about Capacity addition (Sub-para 3-Para B) |SUBJECT: Capacity addition (Sub-para 3-Para B)
- Aster DM Quality Care Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for Financial Year 2025-26'. |SUBJECT: Updates
- Aster DM Quality Care Limited has informed the Exchange about Copy of Newspaper Publication - Dispatch of Notice of 18th Annual General Meeting and Integrated Annual Report for the Financial Year 2025-26 |SUBJECT: Copy of Newspaper Publication
- Aster DM Quality Care Limited has informed the Exchange regarding a press release dated September 04, 2026, titled "Dr. Moopen family picks up additional stake in the Company". |SUBJECT: Press Release
- AS ON DATE : 05-SEP-26
- ASTER DM QUALITY CARE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 28-Sep-2026 |SUBJECT: Notice Of Shareholders Meetings-XBRL
- Aster DM Quality Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026 |SUBJECT: Shareholders meeting
- Aster DM Quality Care Limited has informed the Exchange about Copy of Newspaper Publication regarding intimation of 18th Annual General Meeting scheduled for 28 September 2026 |SUBJECT: Copy of Newspaper Publication
- NAME(S)OF THE ACQUIRER AND ITS(PAC) : Deutsche Bank AG, Singapore Branch acting as the Agent and DB International Trust (Singapore) Limited acting as the Offshore Security Agent for the Lenders

### Fundamentals

Aster DM Healthcare's reported results show a mixed operating trajectory. For the quarter ending March 2024, the company reported a net loss of ₹2.0 crore on sales of ₹974.0 crore, with an Operating Profit Margin (OPM) of 16.0%. This contrasts with the projected figures for March 2025, which anticipate a net profit of ₹86.0 crore on sales of ₹1,000.0 crore, with an OPM of 18.0%. Looking further ahead, projections for March 2026 indicate a net profit of ₹154.0 crore on sales of ₹1,182.0 crore, with an OPM of 19.0%. The company's cash flow from operations has shown significant fluctuations, dropping to ₹158.0 crore in March 2024 from ₹1,834.0 crore in March 2023, and is projected to be ₹425.0 crore in March 2025 and ₹656.0 crore in March 2026. Free Cash Flow was negative at -₹601.0 crore in March 2024, but is projected to turn positive to ₹70.0 crore in March 2025 and ₹179.0 crore in March 2026. The balance sheet shows a substantial decrease in Borrowings from ₹6,075 crore in March 2023 to ₹1,758 crore in March 2024, with a corresponding decrease in Fixed Assets and CWIP. Total Assets and Total Liabilities also saw a significant reduction in March 2024, with projections indicating further changes in future periods. Shareholding patterns show an increasing trend in DII holdings from 13.7% in March 2024 to a projected 27.57% by March 2026, while FII holdings are projected to decrease from 33.48% in March 2024 to 17.18% by March 2026. The number of shareholders has increased from 80,931 in March 2024 to a projected 154,014 in March 2025, before decreasing to 136,892 in March 2026.

Key monitoring areas include the company's ability to sustain the projected growth in sales and operating profit margins, the conversion of operating profit into cash flow from operations, and the management of its debt levels. The significant fluctuations in cash flow from operations and the substantial changes in asset and liability structures warrant close observation. Additionally, the shift in shareholding patterns, with increasing DII and decreasing FII participation, should be monitored.

- For the year ending March 2024, Aster DM Healthcare reported a net loss of ₹2.0 crore on sales of ₹974.0 crore, with an OPM of 16.0%.
- Projections for the year ending March 2025 anticipate a net profit of ₹86.0 crore on sales of ₹1,000.0 crore, with an OPM of 18.0%.
- Cash flow from operations was ₹158.0 crore in March 2024, with projections of ₹425.0 crore for March 2025 and ₹656.0 crore for March 2026.
- Borrowings decreased significantly from ₹6,075 crore in March 2023 to ₹1,758 crore in March 2024.
- DII shareholding is projected to increase from 13.7% in March 2024 to 27.57% by March 2026, while FII shareholding is projected to decrease from 33.48% to 17.18% over the same period.

### Bull Case

Aster DM Healthcare's financial performance shows signs of improvement, particularly in cash flow generation. The company has demonstrated a significant increase in cash flow from operations, alongside a substantial rise in free cash flow between the fiscal years ending March 2019 and March 2020. This operational cash flow growth, coupled with an increase in fixed assets and investments, suggests expansion and development activities. While borrowings have increased, the growth in total assets outpaces the increase in liabilities, indicating a strengthening asset base. The company also shows positive compounded sales growth over the trailing twelve months (TTM), contrasting with a longer-term decline.

- Cash from Operating Activity increased from ₹601 crore in March 2019 to ₹1223 crore in March 2020.
- Free Cash Flow rose from ₹64 crore in March 2019 to ₹715 crore in March 2020.
- Fixed Assets grew from ₹4289 crore in March 2019 to ₹7124 crore in March 2020.
- Compounded Sales Growth was 16% for the TTM period.

- MFs raise healthcare, capital goods allocation in August; consumer weight hits decade low

### Bear Case

Aster DM Healthcare's balance sheet shows a significant increase in borrowings, rising from ₹2,788 crore in March 2019 to ₹5,605 crore in March 2020. This nearly doubled debt level, alongside a substantial increase in fixed assets from ₹4,289 crore to ₹7,124 crore over the same period, indicates a growing financial commitment. While cash flow from operations improved to ₹1,223 crore in March 2020 from ₹601 crore in March 2019, the company also experienced a negative cash flow from financing activities of ₹675 crore in March 2020, compared to a positive ₹134 crore in the prior year. This shift, coupled with a net cash flow decrease to ₹-110 crore from ₹33 crore, suggests potential pressure on liquidity.

- Borrowings increased by 101% from ₹2,788 crore in March 2019 to ₹5,605 crore in March 2020.
- Fixed assets grew by 66% from ₹4,289 crore in March 2019 to ₹7,124 crore in March 2020.
- Cash from financing activities turned negative, decreasing from ₹134 crore in March 2019 to ₹-675 crore in March 2020.
- Net cash flow decreased from ₹33 crore in March 2019 to ₹-110 crore in March 2020.

- MFs raise healthcare, capital goods allocation in August; consumer weight hits decade low

### FAQs

**How has Aster DM Healthcare's financial position changed between March 2019 and March 2020?**

Between March 2019 and March 2020, Aster DM Healthcare's total assets increased from ₹8,928 crore to ₹12,405 crore. This growth was accompanied by an increase in total liabilities from ₹8,928 crore to ₹12,405 crore. Notably, borrowings rose significantly from ₹2,788 crore to ₹5,605 crore, while fixed assets grew from ₹4,289 crore to ₹7,124 crore. Equity capital saw a slight decrease from ₹505 crore to ₹497 crore, while reserves increased from ₹2,709 crore to ₹2,775 crore.

**What has been the trend in Aster DM Healthcare's cash flow from operations and free cash flow?**

Aster DM Healthcare's cash flow from operating activities more than doubled from ₹601 crore in the year ended March 2019 to ₹1,223 crore in the year ended March 2020. Consequently, free cash flow also saw a substantial increase, rising from ₹64 crore in March 2019 to ₹715 crore in March 2020. The company's cash flow from financing activities shifted from a positive ₹134 crore in March 2019 to a negative ₹675 crore in March 2020.

**What recent developments have occurred regarding Aster DM Healthcare's credit rating and expansion plans?**

In September 2026, ICRA upgraded the long-term credit rating of KIMS Healthcare Management Limited (KHML), a material subsidiary of Aster DM Quality Care Limited, to [ICRA]AA (Stable) from [ICRA]AA-. This upgrade was attributed to the improved credit profile of the parent company following a merger. Separately, on August 31, 2026, Aster DM Quality Care Limited announced a plan to add approximately 184 beds to its Trivandrum facility by May 2028, requiring an investment of ₹1.344 billion, to be financed by 70% debt and 30% equity.

**What has been the recent shareholding change involving the promoter group?**

On September 2, 2026, Union (Mauritius) Holdings Ltd., part of the Dr. Azad Moopen family, acquired 46.09 lakh equity shares of Aster DM Quality Care Limited from Centella Mauritius Holdings Limited for approximately ₹350.34 crore. This transaction, at a price of ₹760 per share, increased the promoter group's stake by about 0.57%, bringing their total holding to 24.58%.

**What are the key technical indicators for Aster DM Healthcare as of September 18, 2026?**

As of September 18, 2026, the daily trend indicators for Aster DM Healthcare show a closing price of ₹755.05. The 14-day ADX is 19.82, with the minus DI at 24.68 and the plus DI at 18.29, suggesting a weakening trend. The Supertrend is bearish at ₹797.85. In contrast, the monthly trend indicators are bullish, with the 14-day ADX at 32.14, minus DI at 10.15, and plus DI at 28.76. The Supertrend on a monthly basis is bullish at ₹535.05.

- MFs raise healthcare, capital goods allocation in August; consumer weight hits decade low
- Aster DM Quality Care Limited has informed the Exchange about revision in Credit Rating of a Material Subsidiary |SUBJECT: Credit Rating- Revision
- ASTER DM QUALITY CARE LIMMITED has informed the Exchange about Capacity addition (Sub-para 3-Para B) |SUBJECT: Capacity addition (Sub-para 3-Para B)
- Aster DM Quality Care Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for Financial Year 2025-26'. |SUBJECT: Updates
- Aster DM Quality Care Limited has informed the Exchange about Copy of Newspaper Publication - Dispatch of Notice of 18th Annual General Meeting and Integrated Annual Report for the Financial Year 2025-26 |SUBJECT: Copy of Newspaper Publication
- Aster DM Quality Care Limited has informed the Exchange regarding a press release dated September 04, 2026, titled "Dr. Moopen family picks up additional stake in the Company". |SUBJECT: Press Release
## Technical analytics

- As of: 2026-09-18
- Daily trend: Weak Downtrend
- Weekly trend: Weak Downtrend
- Pivot point: ₹754.37
- Risk regime: Price Risk Currently Contained

### Support levels
- 744.025
- 572.43125
- 547.575

### Resistance levels
- 773.340625
- 800.375
- 823.95

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -0.74% |
| return_10 | -4.06% |
| return_1m | -7.70% |
| return_1y | +22.99% |
| return_20 | -1.38% |
| return_3m | -4.24% |
| return_5 | -1.49% |
| return_6m | +14.06% |
| return_since_start | +44.99% |
| return_ytd | +24.45% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | contained_risk |
| label | Price risk currently contained |
| summary | Recent drawdown and price variability remain within the producer's contained-risk thresholds. |
| maximum_drawdown | -25.59% |
| annualized_volatility | +30.12% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue rises while a large one-time charge reduces reported profit

Aster DM Quality Care reported revenue of ₹1,310.68 crore for the first quarter of FY2026-27, up 21.6% from the same period last year. Reported net profit fell to ₹29.28 crore, driven by a ₹114.38 crore exceptional charge. Excluding this item, profit before tax grew 37.0% year-on-year, showing that underlying earnings expanded despite the one-time deduction.

## Revenue Expansion
Revenue from operations reached ₹1,310.68 crore, the highest level in the available five-quarter series. This represents a 10.85% increase from the preceding March quarter and a 21.6% increase from the year-ago quarter. Revenue has varied across recent quarters, ranging from ₹1,077.87 crore to ₹1,197.21 crore, before rising in the current period.

## Profitability and Exceptional Items
Reported profit before tax declined to ₹86.47 crore, falling 49.7% sequentially and 39.2% year-on-year. The decline was primarily due to an exceptional item before tax of -₹114.38 crore, a notable departure from the ₹0.33 crore gain in the prior quarter and the -₹4.39 crore charge in the year-ago quarter. After a tax expense of ₹48.80 crore, net profit dropped 80.9% sequentially and 68.7% year-on-year to ₹29.28 crore.

When adjusted for the exceptional charge, profit before tax would have been ₹200.85 crore. This figure is 17.1% higher than the March quarter’s adjusted level of ₹171.55 crore and 37.0% higher than the year-ago quarter’s adjusted level of ₹146.55 crore.

## Expense Management
Total expenses rose 9.53% sequentially and 18.91% year-on-year to ₹1,146.86 crore. Revenue growth exceeded expense growth in both comparisons. Consequently, the ratio of expenses to revenue decreased from 88.6% in the March quarter to 87.5% in the current quarter.

## Segment Results
Segment revenue matched total revenue at ₹1,310.68 crore. Segment profit before tax was ₹78.08 crore, down 52.2% sequentially and 42.8% year-on-year from the prior quarter and year-ago quarter, respectively. The segment result includes the impact of the exceptional charge. Reported profit before tax exceeded segment profit before tax by ₹8.39 crore, reflecting unallocated corporate-level items.

## Management Commentary

Aster DM Quality Care reported a strong combined proforma Q1 FY27, with revenue up 20% YoY to INR 2,597 Cr and operating EBITDA up 30% to INR 576 Cr, led by higher patient volumes, improved ARPP IP (+10%), and effective cost management. The merger, effective July 1, 2026, created a network of 39 hospitals across 28 cities with over 10,800 beds, positioning it among India's top three hospital chains.

Management outlined a strategic roadmap: expand bed capacity to over 15,000, unlock 10-15% EBITDA synergies from integration and procurement, and continue leveraging clinical excellence and technology. Kasargod's rapid breakeven and strong specialty growth in oncology, neuroscience, and medical value travel (+62% YoY) underscore demand and operational momentum.

## Key Takeaway
Aster DM Quality Care delivered top-line growth in the June quarter, with revenue reaching a five-quarter high. Reported net profit was heavily impacted by a ₹114.38 crore exceptional charge, which reduced bottom-line earnings by nearly two-thirds compared to the prior year. Underlying profit before tax, however, expanded by 37.0% year-on-year, demonstrating that core operational earnings grew despite the one-time deduction.

### Ratios

## Official filings

- 2026-09-16 — Credit Rating Update: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_16092026153448_SEInt1609S.pdf)
- 2026-09-08 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_PARA_B_15805_WebXMLFile_20260908_105114538.xml)
- 2026-09-05 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_05092026112324_SE_BRSR_2025-26.pdf)
- 2026-09-05 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_05092026143107_SEIntimationSS.pdf)
- 2026-09-04 — Press Release: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_04092026121104_SEintPressReleaseS.pdf)
- 2026-09-04 — Annual Report: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/annual_reports/AR_31473_ASTERDM_2025_2026_A_786030_05092026000613.pdf)
- 2026-09-04 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/NOTICE_OF_SHAREHOLDERS_MEETINGS_15805_WebXMLFile_20260905_002327440.xml)
- 2026-09-04 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_05092026000025_Intimation_AR.pdf)
- 2026-09-02 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_02092026150300_SEIntimation02092026s.pdf)
- 2026-09-01 — Regulatory Filing: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/Disc1_09012026120658_52896.zip)
- 2026-08-31 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_Restructuring_15805_WebXMLFile_20260831_184924428.xml)
- 2026-08-31 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_31082026221752_SE_Int_31082026__Capacity_Addition_s.pdf)
- 2026-08-28 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_28082026182308_SEIntCIHL28082026-s.pdf)
- 2026-08-27 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/NOTICE_OF_SHAREHOLDERS_MEETINGS_15805_WebXMLFile_20260827_163440811.xml)
- 2026-08-27 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_27082026165845_SENewspaperAdPB-s.pdf)
- 2026-08-27 — Regulatory Filing: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM_08272026181641_52978.zip)
- 2026-08-26 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_26082026212243_SE_Intimation.pdf)
- 2026-08-25 — Regulatory Filing: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM291_08252026131104_52864.zip)
- 2026-08-24 — Regulatory Filing: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM_08242026164840_52856.zip)
- 2026-08-14 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_14082026183405_SEIntsign.pdf)
- 2026-08-12 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_15805_WebXMLFile_20260812_164955908.xml)
- 2026-08-12 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_12082026144124_SE_transcript-s.pdf)
- 2026-08-06 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_Restructuring_15805_WebXMLFile_20260806_165358724.xml)
- 2026-08-06 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_15805_WebXMLFile_20260806_145213044.xml)
- 2026-08-06 — Generic Announcement: Aster DM Quality Care Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ASTERDM2_06082026203949_Newspaper_Intimation_signed.pdf)

## News and market events

- 2026-09-15 — MONEYCONTROL: **MFs raise healthcare, capital goods allocation in August; consumer weight hits decade low** — MF holding, August — [Source](https://www.moneycontrol.com/news/business/mfs-raise-healthcare-capital-goods-allocation-in-august-consumer-weight-hits-decade-low-14029813.html)
- 2026-09-03 — Mint: **High conviction picks: Up to 44% upside - 5 large caps, 9 mid and small caps stocks | Check share price target** — Discover high-conviction stock picks that analysts believe could yield significant returns amid market volatility. This article highlights five large-cap stocks and nine mid/small caps, detailing their target prices and potential upside.  — [Source](https://www.livemint.com/market/stock-market-news/high-conviction-picks-up-to-44-upside-5-large-caps-9-mid-and-small-caps-stocks-check-share-price-target-11788421872542.html)
- 2026-09-01 — MONEYCONTROL: **Business news live: Piramal Finance closes Rs 3,850 crore capital raise** — business news live, ipo, gmp, gold, silver, oil price, india — [Source](https://www.moneycontrol.com/news/business/india-business-news-live-business-news-gold-silver-rbi-gmp-ipo-liveblog-14019424.html)
- 2026-08-28 — Economic Times: **Advent, Aster DM in Talks to Buy Yatharth Hospitals** — Advent International and Blackstone-backed Aster DM Quality Care are negotiating to acquire a controlling stake in Yatharth Hospitals and Trauma Care Services, a listed, north India-centric, specialty hospital chain, said people with knowledge of the matter. — [Source](https://economictimes.indiatimes.com/epaper/delhicapital/2026/aug/28/et-front/advent-aster-dm-in-talks-to-buy-yatharth-hospitals/articleshow/133578347.cms)
- 2026-08-28 — MONEYCONTROL: **Aster, Advent eye controlling stake in Yatharth Hospital, says report; shares rise 4.5%** — Aster, advent, yatharth hospitals, yatharth hospitals sale — [Source](https://www.moneycontrol.com/news/business/aster-advent-eye-controlling-stake-in-yatharth-hospital-says-report-shares-rise-4-5-14017367.html)
- 2026-08-20 — CNBC-TV18: **This PSU is up 8% as markets bounce back from slump; Here's a look at the top Nifty 500 movers at market open** — Some Nifty 500 stocks rallied as others slipped on reasons including crude oil's extended rise. Here's a look at today's top gainers and losers at market open — [Source](https://www.cnbctv18.com/photos/market/nifty-500-top-gainers-losers-market-open-muthoot-finance-hdb-financial-hindalco-mmtc-oil-india-19973249.htm)
- 2026-08-19 — MONEYCONTROL: **TPG pares 6.66% stake in Aster DM Quality Care; HDFC MF, Citigroup, Kotak Mahindra AMC among buyers** — Aster DM Quality Care news,Aster DM Quality Care bulk deals — [Source](https://www.moneycontrol.com/news/business/markets/tpg-pares-6-66-stake-in-aster-dm-quality-care-hdfc-mf-citigroup-kotak-mahindra-amc-among-buyers-14010544.html)
- 2026-08-19 — CNBC-TV18: **Aster DM Quality Care Block Deal: Shares worth nearly ₹7,800 crore change hands** — On Tuesday, August 18, CNBC-TV18 reported that Centella Mauritius Holdings was likely to sell 7.2% stake in Aster DM Quality Care, formerly known as Aster DM Healthcare, via a block deal worth around ₹4,780 crore. — [Source](https://www.cnbctv18.com/market/aster-dm-quality-care-share-price-block-deal-value-tpg-seller-buyer-shareholding-19972260.htm)
- 2026-08-19 — BUSINESSTODAY: **Aster DM shares: Why this stock fell 4% today | Block deal** — Aster DM share price today, Aster DM share, Aster DM share price, Aster DM shares, Aster DM block deal — [Source](https://www.businesstoday.in/markets/stocks/story/aster-dm-shares-why-this-stock-fell-4-today-block-deal-549947-2026-08-19)
- 2026-08-18 — CNBC-TV18: **Aster DM Quality Care Block Deal: TPG likely to sell 7.2% stake for ₹4,780 crore** — Shares of Aster DM Quality Care Ltd ended at ₹819.20, down by ₹0.049, or 0.049%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/aster-dm-quality-care-share-price-block-deal-tpg-likely-to-sell-7-2-stake-for-rs-4780-crore-19972133.htm)
- 2026-08-10 — Mint: **Buy or sell: Gift Nifty up despite elusive Iran-Oman deal, Vaishali Parekh recommends three stocks to buy today** — Buy or sell stocks: Vaishali Parekh recommends three stocks to buy today — Grasim Industries, Aster DM Quality Care, and Meesho — [Source](https://www.livemint.com/market/stock-market-news/buy-or-sell-gift-nifty-up-despite-elusive-iran-oman-deal-vaishali-parekh-recommends-three-stocks-to-buy-today-11786324215228.html)
- 2026-08-06 — MONEYCONTROL: **Buy Aster DM Quality Care; target of Rs 920: Prabhudas Lilladher** — Prabhudas Lilladher, Aster DM Quality Care, buy, Recommendations — [Source](https://www.moneycontrol.com/news/business/stocks/buy-aster-dm-quality-care-target-of-rs-920-prabhudas-lilladher-13996375.html)
- 2026-08-06 — CNBC-TV18: **Q1 Results LIVE Updates: ION Exchange, Sheela Foam shares fall 7%; Trent, Hero report today** — Q1 Results LIVE Updates; Trent, Britannia, Lupin, Samvardhana Motherson, Apollo Tyres, Blue Star, Premier Energies, HCC, NCC, PG Electroplast, Emcure Pharma, Firstsource Solutions are some of the many companies that will be reporting their results during the course of Thursday's trading session on Dalal Street. Result reactions today come from PB Fintech, Aurobindo Pharma, Cummins India, GE Vernova T&D, ION Exchange and many others. Watch this space for all the LIVE Q1 result updates, management and brokerage commentary along with stock moves. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-cummins-ge-vernova-td-pb-fintech-trent-britannia-hero-lupin-samil-pgel-apollo-tyres-sci-ncc-hcc-premier-energies-share-price-liveblog-19962840.htm)
- 2026-08-05 — MONEYCONTROL: **Aster DM Quality Care net profit drops on merger related one-off expenses in Q1FY27** — Aster DM Quality Care, Care Hospitals, Evercare, KIMSHealth, Q1 earnings — [Source](https://www.moneycontrol.com/news/business/earnings/aster-dm-quality-care-net-profit-drops-on-merger-related-one-off-expenses-in-q1fy27-13995608.html)
- 2026-08-05 — Mint: **Raja Venkatraman recommends three stocks for 5 August | Stock Market News** — Market expert Raja Venkatraman shares his top stock picks for 5 August. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-5-august-11785890260978.html)
- 2026-07-30 — Economic Times: **Can Manipal Health IPO deliver long-term growth for high risk investors?** — Manipal Health Enterprises plans to raise ₹8,000 crore through a fresh issue for debt repayment and expansion. The company's revenue grew strongly in recent years, while margins faced pressure. Its occupancy rate declined, and geographic concentration is noted in Karnataka. The promoter group's stake will decrease after the initial public offering. Investors may consider waiting for post-listing clarity due to aggressive pricing. — [Source](https://economictimes.indiatimes.com/markets/ipos/fpos/can-manipal-health-ipo-deliver-long-term-growth-for-high-risk-investors/articleshow/132724295.cms)

## Business profile

**Strategic vision:** Integrated healthcare provider operating hospitals, pharmacies, and diagnostic centres.

### Business segments
- **Hospitals:** Operates a network of hospitals across multiple Indian states, with plans for significant bed capacity expansion.
- **Pharmacies:** Provides pharmacy services as part of its integrated healthcare network.
- **Diagnostic Centres:** Operates diagnostic centres as part of its integrated healthcare network.

### Competitive strengths
- Integrated healthcare network
- Strategic presence in non-metro cities

## Related stocks

- [ABBOTINDIA (Healthcare)](https://faxioms.com/stocks/abbotindia) — +5.25%
- [ACUTAAS (Healthcare)](https://faxioms.com/stocks/acutaas) — +3.78%
- [AJANTPHARM (Healthcare)](https://faxioms.com/stocks/ajantpharm) — +1.80%
- [ALKEM (Healthcare)](https://faxioms.com/stocks/alkem) — +2.21%
- [ANTHEM (Healthcare)](https://faxioms.com/stocks/anthem) — +0.12%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/asterdm
Markdown representation: https://faxioms.com/stocks/asterdm?render=md